20014 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the drug release technique; Application systems commanded by energy Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
INFUSABLE SOLUTION FOR LOCAL TREATMENT OF BLOOD VESSELS AND VASCULAR GRAFTS AND METHODS OF USING SUCH A SOLUTION
#302Ataxia therapeutic compositions and methods
#303CHOLINERGIC ANTAGONISM AS AN ADJUNCT TO CANCER THERAPY
#304Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#305Implants for localized drug delivery and methods of use thereof
#306Controlled release dosage form
#307NOVEL PULSATILE DRUG DELIVERY SYSTEM
#308TWO-PIECE, INTERNAL-CHANNEL OSMOTIC DELIVERY SYSTEM FLOW MODULATOR
#309Compositions for improving safety of pharmacological formulations
#310Methods of manufacturing oral formulations
#311AMANTADINE COMPOSITIONS AND METHODS OF USE
#312STABLE NON-AQUEOUS SINGLE PHASE VISCOUS VEHICLES AND FORMULATIONS UTILIZING SUCH VEHICLES
#313HIGHLY CONCENTRATED DRUG PARTICLES, FORMULATIONS, SUSPENSIONS AND USES THEREOF
#314Macrocyclic lactone compounds and methods for their use
#315Methods for treating cancer by activation of BMP signaling
#316Osmotic enhancement of drug/therapeutic delivery to the brain following infusion or injection into the cerebrospinal fluid
#317EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE
#318Methods of providing analgesia
#319Treatment and prevention of learning and memory disorders
#320Compositions and methods for treatment of osteoporosis and other indications
#321DEVICES, FORMULATIONS, AND METHODS FOR DELIVERY OF MULTIPLE BENEFICIAL AGENTS
#322Osmotic delivery device comprising an insulinotropic peptide and uses thereof
#323Sustained release oral dosage form containing dalfampridine
#324Controlled release nanoparticulate matter delivery system
#325Positive pressure capsules and method of manufacturing the same
#326SUSTAINED RELEASE ORAL PHARMACEUTICAL COMPOSITIONS OF TOFACITINIB
#327Implantable drug delivery device
#328Long-acting polymeric delivery systems
#329Drug delivery system and method for controlled and continuous delivery of drugs into the brain by bypassing the blood brain barrier
#330Oral controlled release pharmaceutical compositions of Bepotastine
#331Drug condensation aerosols and kits
#332MICROFABRICATED NANOPORE DEVICE FOR SUSTAINED RELEASE OF THERAPEUTIC AGENT
#333Naloxone single agent and multilayer tablets
#334PEROXIDE REMOVAL FROM DRUG DELIVERY VEHICLE
#335Rapid establishment and/or termination of substantial steady-state drug delivery
#336Polymeric nanocarriers with light-triggered release mechanism
#337NICOTINE SALT WITH META-SALICYLIC ACID AND APPLICATIONS THEREIN
#338Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
#339Controlled release dosage form for once daily administration of dimethyl fumarate
#340Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
#341OSMOTIC DRUG DELIVERY DEVICES, KITS, AND METHODS
#342COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
#343AMANTADINE COMPOSITIONS AND METHODS OF USE
#344AMANTADINE COMPOSITIONS AND METHODS OF USE
#345AMANTADINE COMPOSITIONS AND METHODS OF USE
#346AMANTADINE COMPOSITIONS AND METHODS OF USE
#347COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
#348Controlled release dosage form
#349Osmotic drug delivery system
#350METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING
#351Controlled release dosage form
#352Controlled release dosage form
#353Multi-unit drug delivery devices and methods
#354Methods for intravesical drug delivery and methods and systems for loading devices with drug tablets
#355Electroosmotic pump and fluid pumping system including the same
#356Nicotine salt with meta-salicylic acid
#357Controlled release hydrocodone formulations
#358Controlled release hydrocodone formulations
#359Container
#360Controlled release hydrocodone formulations
#361Controlled release hydrocodone formulations
#362Controlled release hydrocodone formulations
#363Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
#364Pharmaceutical gastro-retentive solid oral dosage form of nilotinib
#365Methods and devices for renal nerve blocking
#366METHOD AND PROCESS FOR THE PRODUCTION OF MULTI-COATED RECOGNITIVE AND RELEASING SYSTEMS
#367Multiple PPI dosage form
#368Topical Formulations and Methods for Drug Delivery
#369Compositions and methods for treatment of osteoporosis and other indications
#370Treatment and prevention of learning and memory disorders
#371Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
#372PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#373HYPERSATURATED GAS IN LIQUID
#374Oxycodone formulations
#375Osmotic drug delivery system
#376Electro-osmotic pump using reversible electrode reaction and fluid pumping system using same
#377Method and composition for hyperthermally treating cells
#378HIGHLY CONCENTRATED DRUG PARTICLES, FORMULATIONS, SUSPENSIONS AND USES THEREOF
#379Heterocyclic compounds and their uses
#380Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters
#381Drug delivery devices and methods for drug delivery
#382Delayed-release formulations, methods of making and use thereof
#383MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE
#384Modified Release Osmotic Pump for PH-Responsive Drug Delivery
#385Hydrazaline hydrochloride pellets and method of preparation
#386Solvent/polymer solutions as suspension vehicles
#387INHALATION-TYPE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GOUT AND PREPARATION METHOD THEREOF
#388Inhalation-type pharmaceutical composition for the treatment of arthritis and preparation method thereof
#389Inhalation-type pharmaceutical composition for the treatment of heart disease and preparation method thereof
#390Inhalation-type pharmaceutical composition for the treatment of Alzheimer's disease and preparation method thereof
#391Inhalation-type pharmaceutical composition for the treatment of Parkinson's disease and preparation method thereof
#392Controlled release hydrocodone formulations
#393POLYMERIC NANOCARRIERS WITH LIGHT-TRIGGERED RELEASE MECHANISM
#394Controlled release hydrocodone formulations
#395Controlled release hydrocodone formulations
#396Microfabricated nanopore device for sustained release of therapeutic agent
#397Microfabricated nanopore device for sustained release of therapeutic agent
#398OSMOTIC DELIVERY DEVICE COMPRISING AN INSULINOTROPIC PEPTIDE AND USES THEREOF
#399PHARMACEUTIC OSMOTIC PUMP PREPARATION
#400Naloxone mono preparation and multilayer tablet
#401Controlled release hydrocodone formulations
#402STABLE NON-AQUEOUS SINGLE PHASE VISCOUS VEHICLES AND FORMULATIONS UTILIZING SUCH VEHICLES
#403Two-piece, internal-channel osmotic delivery system flow modulator
#404IMPLANTABLE DEVICE FOR CONTROLLED DRUG DELIVERY
#405Modified release formulations of a bupropion salt
#406Multicompartmentalized material for the thermostimulated delivery of substances of interest, preparation process and applications
#407Microfabricated nanopore device for sustained release of therapeutic agent
#408COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
#409METHODS OF TREATMENT USING A GASTRIC RETAINED GABAPENTIN DOSAGE FORM
#410Multicompartmentalized material for the thermostimulated delivery of substances of interest, preparation method thereof and uses of the same
#411Once-a-day oxycodone formulations
#412Drug delivery device
#413COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
#414Composition and method for treating neurological disease
#415Devices, formulations, and methods for delivery of multiple beneficial agents
#416Multiple reservoir drug delivery device and methods
#417Multiple reservoir drug delivery device and methods
#418Stabilized formulations of CNS compounds
#419MATRIX AND DEVICE AND USE THEREOF FOR OPTICALLY-CONTROLLED RELEASE OF CHEMICALS
#420Pharmaceutical dosage forms comprising a low-solubility drug and a polymer
#421AMANTADINE COMPOSITIONS AND METHODS OF USE
#422Compositions and methods for treatment of osteoporosis and other indications
#423Treatment and prevention of learning and memory disorders
#424Osmotic delivery systems and piston assemblies for use therein
#425Nanoshells on polymers
#426COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF EYELID SWELLING
#427Drug coating layer
#428Composition and method for treating neurological disease
#429Pharmaceutical formulations of potassium ATP channel openers and uses thereof
#430Polysorbitol-based osmotically active transporter and gene therapy using same
#431Composition and method for treating neurological disease
#432Composition and method for treating neurological disease
#433Composition and method for treating neurological disease
#434PIPERAQUINE MICROCAPSULES AND COMPOSITIONS CONTAINING THEM
#435OSMOTICALLY ACTIVE VAGINAL DELIVERY SYSTEM
#436Triple combination release multi-layered tablet
#437Trans-sclera portal for delivery of therapeutic agents
#438Tofacitinib oral sustained release dosage forms
#439Controlled release hydrocodone
#440System and method for correction of intracerebral chemical imbalances
#441Compositions and methods for treatment of the side-effects associated with administration of cancer chemotherapeutic agents
#442Polymer release system
#443Multiple reservoir drug delivery device and methods
#444SINGLE CHANNEL, MULTIPLE DRUG DELIVERY DEVICE AND METHODS
#445Microfabricated nanopore device for sustained release of therapeutic agent
#446Microfabricated nanopore device for sustained release of therapeutic agent
#447TRANSDERMAL DELIVERY SYSTEM KIT
#448Drug condensation aerosols and kits
#449Parenteral formulations of rasagiline
#450Microfabricated nanopore device for sustained release of therapeutic agent
#451PHARMACEUTICAL ADMINISTRATION FORMS COMPRISING 5-CHLORO-N-(METHYL)-2-THIOPHENECARBOXAMIDE
#452Tumor-targeting gas-generating nanoparticle, method for preparing the same, and tumor-targeting nanoparticle for drug delivery using the same
#453Oral controlled release pharmaceutical compositions of bepotastine
#454Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
#455Biodegradable osmotic pump implant for drug delivery
#456Controlled release nanoparticulate matter delivery system
#457Method and system for drug delivery
#458Two-piece, internal-channel osmotic delivery system flow modulator
#459Multiple PPI dosage form
#460Microfabricated nanopore device for sustained release of therapeutic agent
#461Methods and devices for providing prolonged drug therapy
#462Methods and devices for providing prolonged drug therapy
#463Device, system and methods for the oral delivery of therapeutic compounds
#464Self contained electroosmotic pump and method of making thereof
#465Two-piece, internal-channel osmotic delivery system flow modulator
#466Solid drug tablets for implantable drug delivery devices
#467Osmotic device containing amantadine and an osmotic salt
#468Dual controlled release dosage form
#469OSMOTIC PATCH PUMP
#470Devices, formulations, and methods for delivery of multiple beneficial agents
#471ORAL THERAPEUTIC COMPOUND DELIVERY SYSTEM
#472PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#473Methods of manufacturing viscous liquid pharmaceutical formulations
#474Methods and apparatus for determining formulation orientation of multi-layered pharmaceutical dosage forms
#475Electro-osmotic pumps, systems, methods, and compositions
#476Solvent/polymer solutions as suspension vehicles
#477Sustained delivery of an active agent using an implantable system
#478Solvent/polymer solutions as suspension vehicles
#479Drug condensation aerosols and kits
#480Rapid Establishment and/or Termination of Substantial Steady-State Drug Delivery
#481Controlled release pharmaceutical compositions of tapentadol
#482DRUG DELIVERY SYSTEM FOR TREATMENT OF LIVER CANCER BASED ON INTERVENTIONAL INJECTION OF TEMPERATURE AND pH-SENSITIVE HYDROGEL
#483Nanoshells on polymers
#484SLOW RELEASE PHARMACEUTICAL COMPOSITIONS OF ILOPERIDONE
#485Two-piece, internal-channel osmotic delivery system flow modulator
#486PEROXIDE REMOVAL FROM DRUG DELIVERY VEHICLE
#487System and method for correction of intracerebral chemical imbalances
#488Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof
#489HIGHLY CONCENTRATED DRUG PARTICLES, FORMULATIONS, SUSPENSIONS AND USES THEREOF
#490OSMOTIC PUMP WITH REMOTELY CONTROLLED OSMOTIC FLOW RATE
#491METHODS AND DOSAGE FORMS FOR REDUCING SIDE EFFECTS OF BENZISOZAZOLE DERIVATIVES
#492Controlled release hydrocodone formulations
#493Solvent/polymer solutions as suspension vehicles
#494Drug delivery
#495CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#496OSMOTIC MEDIATED RELEASE SYNTHETIC NANOCARRIERS
#497Implantable Devices and Methods for Treatment of Pain by Delivery of Fentanyl and Fentanyl Congeners
#498Colloidal suspensions comprising a therapeutic agent and squalene
#499PHARMACEUTICAL COMPOSITIONS WITH TETRABENAZINE
#500Nanocarriers for imaging and therapy applications
#501ORAL DOSAGE FORM FOR MODIFIED RELEASE COMPRISING A JAK3 INHIBITOR
#502Two-piece, internal-channel osmotic delivery system flow modulator
#503Oral Pharmaceutical Compositions of Buprenorphine and Method of Use
#504Osmotic delivery comprising an insulinotropic peptide and uses thereof
#505Osmotic pump controlled release tablet and preparation method thereof
#506DRUG COATING PROVIDING HIGH DRUG LOADING AND METHODS FOR PROVIDING THE SAME
#507CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#508Biodegradable osmotic pump implant for drug delivery
#509COMPOSITIONS AND METHODS FOR ONCE-DAILY ADMINISTRATION OF A TRILAYER OSMOTIC TABLET
#510Methods of treatment using a gastric retained gabapentin dosage
#511COMPOSITIONS AND METHODS FOR ONCE-DAILY TREATMENT OF OBSESSIVE COMPULSIVE DISORDER WITH ONDANSETRON
#512DOSAGE FORMS OF APIXABAN
#513METHOD FOR PREPARING A MEDICAL SOLUTION FOR THE MANUFACTURE OF A MEDICAMENT FOR PERITONEAL DIALYSIS
#514Macrocyclic lactone compounds and methods for their use
#515ANTIDEPRESSANT DOSAGE FORM
#516Compositions and Methods for Inactivation of Pathogens at Genital Tract Surfaces
#517PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE
#518Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
#519Methods of treatment using a gastric retained gabapentin dosage
#520Ingestible event markers comprising an ingestible component
#521Methods and systems for prolonged localization of drug delivery
#522Method of inducing a CTL response
#523ORAL DRUG DEVICES AND DRUG FORMULATIONS
#524Sustained release dosage form
#525Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin II antagonist and/or a diuretic
#526PHARMACEUTICAL PRODUCT COMPRISING YEAST
#527Methods of treatment using a gastric retained gabapentin dosage
#528Therapeutic agent for spinal cord injuries
#529NOVEL GASTRO-RETENTIVE DOSAGE FORMS
#530Controlled-Released Osmotic Pump Tablet with Lubricating Layer and the Preparation Thereof
#531COMPOSITION COMPRISING OCAPERIDONE
#532Drug coating providing high drug loading and methods for providing the same
#533NSAID DOSE UNIT FORMULATIONS WITH H2-RECEPTOR ANTAGONISTS AND METHODS OF USE
#534PROPHYLACTIC / THERAPEUTIC AGENT FOR CANCER
#535Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
#536Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
#537Two-piece, internal-channel osmotic delivery system flow modulator
#538HYDROMORPHONE THERAPY
#539Nanoshells on polymers
#540Solvent/polymer solutions as suspension vehicles
#541Polyoxaester suspending vehicles for use with implantable delivery systems
#542Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
#543METAL COORDINATION COMPLEXES OF VOLATILE DRUGS
#544Compositions and methods for inhibiting gastric acid secretion
#545Stabilized formulations of CNS compounds
#546DRUG CONDENSATION AEROSOLS AND KITS
#547Pharmaceutical composition for modified release
#548Sustained delivery of an active agent using an implantable system
#549EXTENDED RELEASE DOSAGE FORM
#550Microfabricated nanopore device for sustained release of therapeutic agent
#551Skin patch laminate body
#552Particle formulations for use in pharmaceutical compositions
#553LOCAL EMBOLIZATION VIA HEATING OF THERMOSENSITIVE POLYMERS
#554METHODS AND DOSAGE FORMS FOR REDUCING SIDE EFFECTS OF BENZISOZAZOLE DERIVATIVES
#555Controlled release metformin formulations
#556Composition and dosage form comprising a particle formulation and suspending vehicle
#557PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE PROPERTIES COMPRISING 5-CHLORO-N-(-METHYL)-2-THIOPHENCARBOXAMID
#558Method of administering amantadine prior to a sleep period
#559OSMOTIC PUMP APPARATUS AND ASSOCIATED METHODS
#560Hydrogel-driven drug dosage form
#561Compositions and Methods for Composite Nanoparticle Hydrogels
#562Osmotic delivery systems and piston assemblies for use therein
#563CONTROLLED RELEASE FORMULATIONS EXHIBITING AN ASCENDING RATE OF RELEASE
#564Process
#565CONTROLLED RELEASE FORMULATIONS EXHIBITING AN ASCENDING RATE OF RELEASE
#566PHARMACEUTICAL PREPARATION CONTAINING NON-DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-2 RECEPTOR BLOCKER
#567Compositions and methods for inhibiting gastric acid secretion
#568PHARMACEUTICAL FORMULATION
#569PHARMACEUTICAL PREPARATION
#570ONCE-A-DAY OXYCODONE FORMULATIONS
#571Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
#572Oral Pharmaceutical Compositions of Buprenorphine and Method of Use
#573METHODS FOR TREATING MYOFASCIAL, MUSCLE, AND/OR BACK PAIN
#574Treatment of malaria
#575Rapid establishment and/or termination of substantial steady-state drug delivery
#576Implantable device for controlled drug delivery
#577PHARMACEUTICAL COMPOSITIONS
#578Compositions, Methods, and Systems for SIRNA Delivery
#579Controlled release hydrocodone formulations
#580Drug delivery
#581DOSING REGIMENS FOR THE TREATMENT OF CANCER
#582AN IMPLANTABLE DRUG DEPOT HAVING A REVERSIBLE PHASE TRANSITION MATERIAL FOR TREATMENT OF PAIN AND/OR INFLAMMATION
#583METHOD OF MANUFACTURING A COMPOSITE BASED ON COMPLEXES OF CONTROLLED STABILITY
#584Implantable drug delivery devices and methods of making the same
#585Solid drug tablets for implantable drug delivery devices
#586Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
#587SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#588Controlled porous osmotic pump tablets of high permeable drugs and the preparation process thereof
#589TRANSDERMAL PATCH DEVICE
#590ANTIDEPRESSANT DOSAGE FORM
#591SKIN PATCH LAMINATE BODY
#592Rate-Controlled Oral Dosage Formulations
#593Modified-release formulations of a bupropion salt
#594Abuse-Resistant Pharmaceutical Dosage Form
#595CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#596Injection molding process for the preparation of an oral delivery device for the pharmaceutically active agent
#597Formulations of desvenlafaxine
#598Encapsulation and controlled release of small molecules for intracellular delivery using thermally responsive nanocapsules
#599OROS PUSH-STICK FOR CONTROLLED DELIVERY OF ACTIVE AGENTS
#600System and method for correction of intracerebral chemical imbalances